Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Genetics Focus::HERSite

Cancer Genetics has launched Focus::HERSite, a genomic panel for hereditary breast and ovarian cancer syndrome. The panel analyzes the 16 most common genes associated with breast and ovarian cancers. It also provides comprehensive coverage of BRCA1 and BRCA2, with the ability to detect large genomic rearrangements, duplications, and deletions in those genes, the company said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.